Pipeline Report 2023: Game on for blockbusters, novel MOAs a

The industry awaits a number of readouts and approvals for drugs that address market gaps and enrich treatment landscapes — with huge sales potential to boot.

Related Keywords

Canada , Australia , Roshni Basu , Astrazeneca Daiichi Sankyo , Astrazeneca Soliris , Alessandra Franceschetti , Amanda Weyerbacher , Eli Lilly Taltz , Astrazeneca Fasenra , Novo Nordisk Wegovy , Abbvie Humira , Novarti Cosentyx , Eric Blouin , Lavan Khandan , Verona Pharma , Bimekizumab Bimzelx , Jasmine Lucas , Sam Leach , Eli Lilly , Hannah Brown , Sanofi Alnylam , Ashley Ingles , Lindsay Weisker , Keytruda Merck , Mamting Thoo , Lindsey Sohl , Sandra Teoh , Elizabeth Machado , Simone Gabriele , Amgen , Inthought Research , Novartis , Pfizer , Drug Administration , Astrazeneca , Credit Suisse , Novo Nordisk , Inflation Reduction Act , Adis Insight , Leon Henderson Maclennan , Aine Kyle , Penny Robinson , Daiichi Sankyo , Initial Phase , Respiratory System Lungs Anatomy , Michelle Tan , Bavarian Nordic ,